Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?
- PMID: 16483549
- DOI: 10.1016/j.biopsych.2005.11.023
Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?
Abstract
Background: An association between the activity of the hypothalamic-pituitary-adrenocortical (HPA) axis and alcohol intake behavior is currently discussed. We examined the relationship between efficacy of pharmacological anticraving treatment and HPA axis activity in the relapse prevention treatment of alcoholism.
Methods: In 160 patients suffering from alcoholism, we measured plasma adrenocorticotropic hormone (ACTH) and cortisol during placebo-controlled relapse prevention treatment with naltrexone and/or acamprosate.
Results: In the placebo group, ACTH and cortisol decreased during early abstinence. Treatment with naltrexone and acamprosate prevented this course. Increased ACTH and cortisol during treatment was associated with a reduced risk of relapse.
Conclusions: These findings suggest that heightened HPA responsiveness might contribute to relapse-preventing effects of anticraving compounds in alcoholism.
Similar articles
-
Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism.Neuropsychopharmacology. 2002 Jun;26(6):778-88. doi: 10.1016/S0893-133X(01)00416-X. Neuropsychopharmacology. 2002. PMID: 12007748
-
The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin.Brain Res. 2009 Dec 11;1305 Suppl:S2-6. doi: 10.1016/j.brainres.2009.09.093. Epub 2009 Sep 30. Brain Res. 2009. PMID: 19799882 Clinical Trial.
-
Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.Psychopharmacology (Berl). 2002 Feb;160(1):19-29. doi: 10.1007/s002130100919. Epub 2002 Jan 22. Psychopharmacology (Berl). 2002. PMID: 11862370 Clinical Trial.
-
Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence.Am J Addict. 2003;12(s1):s3-s11. doi: 10.1111/j.1521-0391.2003.tb00492.x. Am J Addict. 2003. PMID: 14972776 Review.
-
[Pharmacological treatment of alcohol dependence. Acamprosate and naltrexone offer new approach].Lakartidningen. 1997 Jul 23;94(30-31):2645-8. Lakartidningen. 1997. PMID: 9273426 Review. Swedish. No abstract available.
Cited by
-
Methylation of the Oxytocin, Oxytocin Receptor, and Vasopressin Gene Promoters in Tobacco Use Disorder during Cessation.Neuropsychobiology. 2024;83(1):28-40. doi: 10.1159/000535663. Epub 2024 Jan 5. Neuropsychobiology. 2024. PMID: 38185116 Free PMC article.
-
The Effects of the Lockdown during the COVID-19 Pandemic on Alcohol and Tobacco Consumption Behavior in Germany.Eur Addict Res. 2021;27(4):242-256. doi: 10.1159/000515438. Epub 2021 Apr 26. Eur Addict Res. 2021. PMID: 33902030 Free PMC article.
-
Central amygdala mineralocorticoid receptors modulate alcohol self-administration.Neuropharmacology. 2020 Dec 15;181:108337. doi: 10.1016/j.neuropharm.2020.108337. Epub 2020 Sep 29. Neuropharmacology. 2020. PMID: 33007359 Free PMC article.
-
Differences in pituitary-adrenal reactivity in Black and White men with and without alcohol use disorder.Psychoneuroendocrinology. 2019 Feb;100:180-189. doi: 10.1016/j.psyneuen.2018.10.004. Epub 2018 Oct 9. Psychoneuroendocrinology. 2019. PMID: 30347319 Free PMC article.
-
Naltrexone alters alcohol self-administration behaviors and hypothalamic-pituitary-adrenal axis activity in a sex-dependent manner in rats.Pharmacol Biochem Behav. 2018 Apr;167:50-59. doi: 10.1016/j.pbb.2018.02.003. Epub 2018 Feb 24. Pharmacol Biochem Behav. 2018. PMID: 29486222 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
